cardiome.com
域名年龄: 23年9个月9天HTTP/1.1 200 OK 服务器:nginx/1.4.5 访问时间:2014年03月03日 00:26:23 类型:text/html; charset=utf-8 Transfer-Encoding: chunked 连接:keep-alive 语言环境:PHP/5.2.17 过期时间:1978年11月19日 13:00:00 缓存控制:必须更新 设置Cookie:SESSce717fede686461401b081c62255eec6=242af7ee1df19cac38f58c79563a8676; expires=Tue, 25-Mar-2014 19:59:43 GMT; path=/; domain=.cardiome.com 修改日期:2014年02月21日 01:15:57 Content-Encoding: gzip 网站编码:utf-8
CARDIOME - inspiring scienceLogin Search this site: Contact Home About UsOverview Corporate Mission Management Team Directors Business DevelopmentOverview PipelineOverview Atrial Fibrillation Vernakalant IV InvestorsOverview Financials News FAQs CareersOverview Current Opportunities BRINAVESS™Ordering BRINAVESS™ Innovation for Patients..." /> Innovation for Patients... with Atrial Fibrillation: through commercializing and developing therapies Learn More Innovation for Patients..." /> Innovation for Patients... with Atrial Fibrillation: to improve their health and quality of life Learn More Innovation for Patients..." /> Innovation for Patients... with Atrial Fibrillation: through perseverance and creativity Learn More From Discovery to Launch In collaboration with Merck, the intravenous formulation of Cardiome's lead molecule, vernakalant (IV), was granted marketing approval in September, 2010 in the European Union, Iceland and Norway under the trademark BRINAVESSTM for rapid conversion of recent onset AF to sinus rythm in adults. It continues to expand into new markets around the world. + READ MORE Ordering BRINAVESS™ Links to Stock Quotes: NASDAQ: CRME TSX: COM [View] News 20 February, 2014 Cardiome Announces C$30 Million Primary And Secondary Common Share Offering + Click here for Press Release 19 February, 2014 Cardiome Announces Update In Commercialization Partnership For BRINAVESS™ In Select European Markets + Click here for Press Release + read all news Financials 15 May, 2013 2013 Q1 - Financial Statements 15 May, 2013 2013 Q1 - MD&A 14 November, 2012 2012 Q3 - MD&A 14 November, 2012 2012 Q3 - Financial Statements + VIEW ALL REPORTS Careers Become a member of the Cardiome Team. View our current opportunities + Learn More About CardiomeCardiome is a research-based biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the quality of life and health of patients. We strive to find innovative medicines that provide values to patients, physicians and healthcare systems.+ CONTACT US Copyright 2014 Cardiome Pharma Corp. All rights reserved. | See legal terms for use of site.
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2024-12-18 04:04, Process in 0.0090 second.